By Maymunah Tosin Adeyemo
Can Nigerians confidently trust the medicines they take, the food they eat and the cosmetics they apply to their bodies? This is a question that deserves urgent national attention as fake, falsified and substandard products continue to threaten the safety and wellbeing of consumers. The proliferation of these products is often treated as a matter of commercial fraud, consumer rights or regulatory non-compliance. However, the consequences go far beyond financial losses. A falsified medicine can delay treatment, worsen an illness or expose a patient to harmful substances. Contaminated food can trigger disease outbreaks, while unsafe cosmetics can expose consumers to dangerous chemicals. Fake products are, therefore, not merely an economic nuisance; they represent a serious and preventable public health threat.
The danger becomes even more concerning when the wider implications are considered. A person who purchases an ineffective medicine may experience prolonged illness, treatment failure or complications that could have been avoided. Substandard antimicrobial medicines can also contribute to antimicrobial resistance, making infections increasingly difficult to treat. Beyond individual suffering, families may incur additional medical expenses, while already burdened healthcare facilities must manage the consequences of preventable harm. Equally damaging is the erosion of public confidence in legitimate manufacturers, healthcare products and regulatory institutions. A society where consumers cannot distinguish safe products from dangerous imitations is one in which public health protection is fundamentally compromised. The question, therefore, is not simply how many fake products are seized, but how many Nigerians are protected from exposure in the first place.
Why does the problem persist despite the existence of regulatory institutions such as the National Agency for Food and Drug Administration and Control (NAFDAC)? The answer lies partly in the complexity of product supply chains and the weaknesses that can emerge at different stages. From manufacturing and importation to storage, distribution and retail, every stage presents opportunities for unsafe products to enter the market. Poor storage practices, inadequate monitoring, unauthorised sales and the expansion of informal and online markets make effective oversight more difficult. Where product traceability is weak, identifying the source of falsified goods and preventing their further circulation becomes a major challenge. Although enforcement remains indispensable, a system that primarily reacts after violations occur will struggle to eliminate a problem that requires prevention at every stage of the supply chain.
The economic realities confronting Nigerian consumers also deserve attention. When genuine medicines and essential products are expensive or difficult to obtain, people may turn to cheaper alternatives without knowing their actual source or quality. Others may simply lack the information or practical knowledge required to identify suspicious products. Even informed consumers can be deceived by convincing counterfeits. This reality makes it unfair and counterproductive to place the burden of product safety entirely on consumers. Public education campaigns must recognise the influence of affordability, availability, language and literacy on purchasing decisions. Furthermore, the scale of regulatory activity must be matched with measurable improvements in public safety. NAFDAC reported 5,542 enforcement activities across regulated product categories between January and August 2026. While this demonstrates substantial intervention, the continued presence of unsafe products raises an important question: how effectively are these interventions translating into prevention, stronger supply-chain controls and reduced consumer exposure?
Nigeria must consequently move from an enforcement-centred approach to a coordinated, prevention-driven public health response. Regulatory monitoring needs to extend beyond retail outlets to manufacturing facilities, importation points, warehouses and distribution networks. Manufacturers, importers and distributors should be held accountable for maintaining product quality and integrity throughout the supply chain. Stronger traceability systems, timely information-sharing and effective surveillance can help identify the sources of unsafe products and stop their distribution before they reach consumers. Government should also address the affordability and availability of legitimate products, particularly essential medicines and other goods that households depend on. It is unrealistic to expect consumers to consistently make safe choices when genuine products remain inaccessible or unaffordable. Removing fake products from the market must therefore go hand in hand with improving access to safe and quality-assured alternatives.
Public awareness and institutional collaboration need to also become central to the response. Consumer education should go beyond generic warnings about counterfeit products to provide practical guidance on safer purchasing decisions, reliable sources of product information and channels for reporting suspicious products or adverse reactions. Such messages should be communicated in accessible languages and through channels that reach different communities. Equally important is stronger collaboration among regulatory agencies, healthcare professionals, law enforcement institutions, manufacturers, distributors and civil society organisations. Information from consumers, healthcare facilities, product surveillance and enforcement operations should inform timely investigations and coordinated action. Reporting mechanisms must be accessible, responsive and trusted. In addition, government and regulatory institutions should measure progress not only by the number of raids conducted or products seized, but also by reductions in unsafe products in circulation, repeated violations, consumer exposure and the barriers people face in accessing legitimate products.
Ultimately, the fight against fake products must be understood as a responsibility to protect lives, not merely to police markets. Nigeria cannot achieve meaningful consumer protection without a system that safeguards product quality from the point of production to the moment of purchase. Regulatory agencies must enforce standards, businesses must uphold their responsibilities, healthcare professionals must support public awareness, and government must create the conditions for safe products to remain accessible and affordable. Consumers, too, should be empowered to ask questions and report suspicious products without being made to bear the responsibility for regulatory failures. The true measure of success is not the volume of counterfeit goods displayed at enforcement briefings, but the number of unsafe products prevented from reaching Nigerian households. Protecting public health must begin before harm occurs.
Maymunah ‘Tosin Adeyemo is a public health and project management professional and can be contacted via mzadeyemo@gmail.com

